donepezil has been researched along with Dyskinesia, Medication-Induced in 9 studies
Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Donepezil was added to their usual treatment for 8 weeks." | 1.33 | Beneficial effect of donepezil in the treatment of elderly patients with tardive movement disorders. ( Bergman, J; Brettholz, I; Dwolatzky, T; Lerner, V, 2005) |
| "Ten patients with schizophrenia or schizoaffective disorder who received stable doses of antipsychotics and met DSM-IV criteria for TD were treated with donepezil, 5 to 10 mg/day, for 6 weeks after a 2-week baseline period." | 1.31 | Treatment of tardive dyskinesia with donepezil: a pilot study. ( Campbell, EC; Caroff, SN; Gallop, R; Havey, J; Mann, SC; Sullivan, KA, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ogunmefun, A | 1 |
| Hasnain, M | 1 |
| Alam, A | 1 |
| Osuala, T | 1 |
| Regenold, WT | 1 |
| Shinfuku, M | 1 |
| Nakajima, S | 1 |
| Uchida, H | 1 |
| Watanabe, K | 1 |
| Kocha, H | 1 |
| Kashima, H | 1 |
| Oh, YS | 1 |
| Kim, JS | 1 |
| Ryu, DW | 1 |
| Lee, KS | 1 |
| Rozzini, L | 1 |
| Ghianda, D | 1 |
| Trabucchi, M | 1 |
| Padovani, A | 1 |
| Bergman, J | 1 |
| Dwolatzky, T | 1 |
| Brettholz, I | 1 |
| Lerner, V | 1 |
| Schopick, D | 1 |
| Caroff, SN | 3 |
| Martine, R | 1 |
| Kleiner-Fisman, G | 1 |
| Eisa, M | 1 |
| Lorry, A | 1 |
| Gallop, R | 2 |
| Stern, MB | 1 |
| Duda, JE | 1 |
| Campbell, EC | 2 |
| Havey, JC | 1 |
| Sullivan, KA | 2 |
| Katz, IR | 1 |
| Mann, SC | 2 |
| Havey, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Varenicline on Smoking Cessation in Patients With Schizophrenia: Evaluation of Antipsychotic Drug-Induced Neurological Symptoms as Correlates of Response[NCT03495024] | Phase 4 | 10 participants (Anticipated) | Interventional | 2019-01-01 | Recruiting | ||
| Treatment of Tardive Dyskinesia With Galantamine[NCT00164242] | Phase 4 | 36 participants | Interventional | 2002-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for donepezil and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Effect of donepezil on tardive dyskinesia.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Cholinesterase Inhibitors; Cross-Over Studies; Donepe | 2009 |
Treatment of levodopa-induced dyskinesias with donepezil.
Topics: Aged; Antiparkinson Agents; Donepezil; Dyskinesia, Drug-Induced; Humans; Indans; Levodopa; Male; Mid | 2006 |
7 other studies available for donepezil and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Pisa syndrome caused by an acetylcholinesterase inhibitor in a patient with dementia with Lewy bodies.
Topics: Aged; Cholinesterase Inhibitors; Donepezil; Dyskinesia, Drug-Induced; Female; Humans; Indans; Lewy B | 2011 |
Donepezil induced antecollis in a patient with Parkinson's disease dementia.
Topics: Aged; Cholinesterase Inhibitors; Dementia; Donepezil; Dyskinesia, Drug-Induced; Female; Humans; Inda | 2013 |
Severe worsening of parkinsonism in Lewy body dementia due to donepezil.
Topics: Acetylcholine; Aged; Basal Ganglia; Cholinesterase Inhibitors; Disease Progression; Donepezil; Dopam | 2004 |
Beneficial effect of donepezil in the treatment of elderly patients with tardive movement disorders.
Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Cholinesterase Inhibitors; Cog | 2005 |
Donepezil and tardive dyskinesia.
Topics: Adolescent; Cholinesterase Inhibitors; Donepezil; Dyskinesia, Drug-Induced; Humans; Indans; Male; Pi | 2005 |
Treatment of tardive dyskinesia with donepezil.
Topics: Adult; Aged; Antipsychotic Agents; Cholinesterase Inhibitors; Donepezil; Drug Administration Schedul | 2001 |
Treatment of tardive dyskinesia with donepezil: a pilot study.
Topics: Adult; Aged; Antipsychotic Agents; Donepezil; Dose-Response Relationship, Drug; Drug Administration | 2001 |